Deb@G
@debmaj.bsky.social
#Comms/PR/Marketing Leader.#Newsjunkie, #mentoring, #travel, #sports, #books. FACTS matter, not hyperbole. Go Orange. Opinions are my own.
182 days into Donald Trump's term, his net approval rating is -14%, down 1.6 points since last week.
41% approve, 55% disapprove, 4% not sure.
Check out the data.
www.economist.com/interactive/...
Last updated on July 21st 2025
41% approve, 55% disapprove, 4% not sure.
Check out the data.
www.economist.com/interactive/...
Last updated on July 21st 2025
Donald Trump’s approval rating
Follow our presidential approval rating poll tracker to see how favourably Americans view Mr Trump
www.economist.com
July 21, 2025 at 11:54 PM
182 days into Donald Trump's term, his net approval rating is -14%, down 1.6 points since last week.
41% approve, 55% disapprove, 4% not sure.
Check out the data.
www.economist.com/interactive/...
Last updated on July 21st 2025
41% approve, 55% disapprove, 4% not sure.
Check out the data.
www.economist.com/interactive/...
Last updated on July 21st 2025
Reposted by Deb@G
Welcome to BookSky! 💙📚
1️⃣ save/pin the feed if you're enjoying it
2️⃣ repost to help us find more bibliophiles
3️⃣ use 💙📚 or 📚💙 to post to feed
4️⃣ more niche feeds on my profile (some are NSFW)
FAQ 👉🏻 bit.ly/bookskyFAQ
1️⃣ save/pin the feed if you're enjoying it
2️⃣ repost to help us find more bibliophiles
3️⃣ use 💙📚 or 📚💙 to post to feed
4️⃣ more niche feeds on my profile (some are NSFW)
FAQ 👉🏻 bit.ly/bookskyFAQ
December 17, 2023 at 10:53 PM
Welcome to BookSky! 💙📚
1️⃣ save/pin the feed if you're enjoying it
2️⃣ repost to help us find more bibliophiles
3️⃣ use 💙📚 or 📚💙 to post to feed
4️⃣ more niche feeds on my profile (some are NSFW)
FAQ 👉🏻 bit.ly/bookskyFAQ
1️⃣ save/pin the feed if you're enjoying it
2️⃣ repost to help us find more bibliophiles
3️⃣ use 💙📚 or 📚💙 to post to feed
4️⃣ more niche feeds on my profile (some are NSFW)
FAQ 👉🏻 bit.ly/bookskyFAQ
Reposted by Deb@G
Good morning, Bluesky. Today’s #GoodMorningNews: a trial at Washington University’s school of medicine has shown great results for a vaccine that would prevent recurrence for a particularly aggressive form of breast cancer. It’s a small trial, but 3 years later 16/18 participants remain cancer free
Vaccine shows promise against aggressive breast cancer | WashU Medicine
Clinical trial targeted recurrence of hard-to-treat triple-negative breast cancer
medicine.washu.edu
November 16, 2024 at 3:09 PM
Good morning, Bluesky. Today’s #GoodMorningNews: a trial at Washington University’s school of medicine has shown great results for a vaccine that would prevent recurrence for a particularly aggressive form of breast cancer. It’s a small trial, but 3 years later 16/18 participants remain cancer free